JANE STREET GROUP, LLC - RELMADA THERAPEUTICS INC ownership

RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 75 filers reported holding RELMADA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.00 and the average weighting 0.2%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of RELMADA THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$29,810
-92.8%
12,118
-89.8%
0.00%
Q4 2022$413,855
+76.9%
118,583
+860.3%
0.00%
Q2 2022$234,000
-90.4%
12,348
-86.3%
0.00%
Q1 2022$2,439,000
+86.6%
90,343
+121.3%
0.00%
Q2 2021$1,307,000
+43.9%
40,819
+44.2%
0.00%
Q4 2020$908,000
-68.1%
28,300
-55.5%
0.00%
-100.0%
Q2 2020$2,845,000
+949.8%
63,598
+701.4%
0.00%
Q1 2020$271,0007,9360.00%
Other shareholders
RELMADA THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Guild Investment Management, Inc. 111,550$274,4130.39%
Deep Track Capital, LP 2,837,818$6,981,0320.32%
apricus wealth, LLC 77,329$219,6140.19%
PARSONS CAPITAL MANAGEMENT INC/RI 873,312$2,148,3480.16%
Palo Alto Investors LP 732,400$1,801,7040.15%
RTW INVESTMENTS, LP 2,131,835$5,244,3140.10%
AdvisorShares Investments LLC 112,898$277,7290.08%
GSA CAPITAL PARTNERS LLP 271,524$6680.07%
Spotlight Asset Group, Inc. 20,000$49,2000.04%
Savior LLC 3,500$8,6100.04%
View complete list of RELMADA THERAPEUTICS INC shareholders